Results 41 to 50 of about 3,199 (178)

French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 6, Page 963-979, June 2026.
New 2025 French guidelines update psoriasis management with revised algorithms integrating recent systemic therapies. They recommend methotrexate, adalimumab or ustekinumab as first‐line treatments and provide guidance for special psoriasis forms, comorbidities, pregnancy and long‐term management.
Marie Masson Regnault, Emilie Brenaut, Marie‐Emeline Marniquet, Carla Berthault, Lea Canoen, Clarisse Marcombes, Audrey Melin, Raphaël Ouakrat, Julie Charles, Stephane Mouret, Olivier Potie, Laetitia Penso, Laura Pina Vegas, Guillaume Larid, Marine Roux, Colombe Bougeard, Sandy Sylvain, Clara Labonne, Tania Randriamiarana, Da Hee Pitaud, Floriane Etheve, Jeremy Gottlieb, Laurie Gouillon, Marine Chastagner, Emilie Sbidian, Hélène Aubert, on behalf of the Psoriasis Research Group of the French Society of Dermatology (Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie), Hélène Aubert, Marie Masson Regnault, Emilie Brenaut, Emilie Sbidian, Laura Pina Vegas, Laetitia Penso, Jeremy Gottlieb, Marine Roux, Clara Labonne, Tania Randriamiarana, Floriane Etheve, Da Hee Pitaud, Marie‐Emeline Marniquet, Carla Berthault, Clarisse Marcombes, Audrey Melin, Colombe Bougeard, Julie Charles, Olivier Potie, Léa Canoen, Laurie Gouillon, Marine Chastagner, Sandy Sylvain, Guillaume Larid, Raphaël Ouakrat   +51 more
wiley   +1 more source

Study of Down Regulation IL-37 Expression in Breast Cancer Tumoral Tissues and its Association with Tumoral Grade 3

مجله علمی دانشگاه علوم پزشکی کردستان, 2018
Background and Aim: Nowadays, breast cancer is the most common cancer among women in the world. Considering the high prevalence, identification of diagnostic markers can be useful for early diagnosis and cancer management.
Marzieh Ghafari Farsani, Somayeh Reiisi, Maryam peymani   +2 more
doaj  

Lack of association between MTHFR C677T polymorphism and breast cancer risk in Ahvaz, west south-Iran

Advanced Biomedical Research, 2016
Background: Association between C677T polymorphism of the methylenetetrahydrofolate reductase (MTHFR), a key enzyme involved in folate metabolism and DNA methylation, and breast cancer risk are inconsistent.
Ghorban Mohammadzadeh, Maryam Karimi, Mohammad Bazyar, Seyed-Mohammad Hosseini   +3 more
doaj   +1 more source

Paediatric‐onset autoimmune cytopenia: How can we reduce the long‐term mortality?

British Journal of Haematology, Volume 209, Issue 2, Page 825-829, August 2026.
Nathalie Aladjidi, Thierry Leblanc, Helder Fernandes, Capucine Picard, Jacinta Bustamante, Frédéric Rieux‐Laucat, Mathieu Fusaro, Maud Tusseau, Charlotte Durand‐Teyssier, Emma Cohendy, Jérôme Granel, Stéphane Ducassou, Agathe Escudier, Despina Moshous, Marc Michel, Bertrand Godeau, Sébastien Héritier, Mony Fahd, Brigitte Bader‐Meunier, Alain Fischer, Guy Leverger, All collaborators from the French Paediatric Haemato‐Immunologic CEREVANCE Network   +21 more
wiley   +1 more source

Outcomes and salvage strategies for large B‐cell lymphoma progressing after second‐line CAR T‐cell therapy: A DESCAR‐T study from the LYSA group

HemaSphere, Volume 10, Issue 5, May 2026.
Abstract Relapse after chimeric antigen receptor (CAR) T‐cell therapy in large B‐cell lymphoma (LBCL) is associated with a dismal prognosis. Although Phase 3 trials have established CAR T‐cells as standard second‐line (2L) therapy, outcomes and optimal management after relapse in this setting remain unknown because no real‐world data are currently ...
Pierre Sesques, Guillaume Manson, Guillaume Cartron, François‐Xavier Gros, Franck Morschhauser, Cristina Castilla‐Llorente, Gabriel Brisou, Pierre Bories, Catherine Thieblemont, Laurianne Drieu La Rochelle, Benoit Tessoulin, Axel André, Cedric Rossi, Jérôme Paillassa, Stephanie Guidez, Antoine Capes, Laura Herbreteau, Sylvain Choquet, Jacques‐Olivier Bay, Adrien Chauchet, Laure Lebras, Fabien Claves, Julie Abraham, Jean‐Valère Malfuson, Marie‐Thérèse Rubio, Justine Decroocq, Luc‐Matthieu Fornecker, Gandhi Damaj, Ludovic Fouillet, Magalie Joris, Michael Loschi, Olivier Hermine, Hadia Hafirassou, Emelie Van Zele, Vivien Dupont, Steven Le Gouill, Roch Houot, Vincent Camus   +37 more
wiley   +1 more source

Surgical Management of Zollinger‐Ellison Syndrome in Multiple Endocrine Neoplasia Type 1 an AFCE and GTE Cohort Study. (Association Francophone de Chirurgie Endocrinienne and Groupe d'étude des Tumeurs Endocrines)

World Journal of Surgery, Volume 50, Issue 5, Page 1300-1311, May 2026.
To describe surgical indications, procedures and outcomes in patients operated for Zollinger‐Ellison syndrome (ZES) in multiple endocrine neoplasia type 1 (MEN1) using a large nationwide cohort. ABSTRACT Objective To describe surgical indications, procedures and outcomes in patients operated for Zollinger‐Ellison syndrome (ZES) in multiple endocrine ...
Sébastien Gaujoux, François Pattou, Guillaume Cadiot, Mustapha Adham, Philippe Bachellier, Jean‐Pierre Bail, Robert Caiazzo, Nicolas Carrere, Philippe Chaffanjon, Sophie Deguelte, Gianluca Donatini, Bertrand Dousset, Matthieu Faron, Caroline Gronnier, Bruno Heyd, Jean‐Christophe Lifante, Jean Lubrano, Nicolas Meurisse, Eric Mirallié, Nicolas Santucci, Alain Sauvanet, Frédéric Sebag, Laurent Sulpice, Baudoin Thebault, Jean‐Jacques Tuech, Thomas Walter, Christine Binquet, Pierre Goudet   +27 more
wiley   +1 more source

HLA-DR expression in melanoma: from misleading therapeutic target to potential immunotherapy biomarker

Frontiers in Immunology
Since the advent of anti-PD1 immune checkpoint inhibitor (ICI) immunotherapy, cutaneous melanoma has undergone a true revolution with prolonged survival, as available 5-year updates for progression-free survival and overall survival demonstrate a durable
Karim Amrane, Karim Amrane, Coline Le Meur, Benjamin Besse, Benjamin Besse, Patrice Hemon, Pierre Le Noac’h, Pierre Le Noac’h, Olivier Pradier, Christian Berthou, Christian Berthou, Ronan Abgral, Ronan Abgral, Arnaud Uguen, Arnaud Uguen   +14 more
doaj   +1 more source

The impact of breast reconstruction on the quality of life of women after mastectomy

Journal of Education, Health and Sport, 2017
Introduction: Breast cancer is the most common tumor among women. The treatment of breast cancer is becoming increasingly less mutilating but in many cases it requires drastic surgical procedures.
Agnieszka Rzońca, Adam Fronczak
doaj   +3 more sources

Integration of circulating tumor DNA profiling in the risk stratification of classical Hodgkin lymphoma in children, adolescents, and young adults

HemaSphere, Volume 10, Issue 4, April 2026.
Abstract This study aimed to define the potential role of circulating tumor DNA (ctDNA) in children, adolescents, and young adults (CAYA) with classical Hodgkin lymphoma (cHL). This prospective trial was conducted in France between 2019 and 2023 and recruited CAYA patients (≤25 years old) with a new diagnosis of cHL.
Mathieu Simonin, Mathieu Viennot, Stéphanie Haouy, Stéphane Ducassou, Catherine Curtillet, Nathalie Garnier, Aurélie Phulpin, Catherine Paillard, Charlotte Rigaud, Marie‐Laure Couec, Liana Carausu, Jacinthe Bonneau, Isabelle Pellier, Melissa Barbati, Frédéric Millot, Marie‐Émilie Dourthe, Justina Kanold, Pascale Schneider, Jean‐Louis Stephan, Camille Leglise, Claire Pluchart, Pierre‐Julien Viailly, Victor Michel, Sabah Boudjemaa, Bénédicte Jonca, Thierry Leblanc, Judith Landman‐Parker, Fabrice Jardin   +27 more
wiley   +1 more source

Towards Sustainable Magnetic Resonance Neuro Imaging: Pathways for Energy Optimization and Cost Reduction Strategies

Applied Sciences
We evaluated the energy consumption of a 3T MRI using a central monitoring system, focusing on hospital energy costs during peak winter months from 2021 to 2023.
Zélie Alerte, Mateusz Chodorowski, Samy Ammari, Alex Rovira, Julien Ognard, Ben Salem Douraied   +5 more
doaj   +1 more source